{{Rsnum
|rsid=12917707
|Chromosome=16
|position=20356368
|Orientation=plus
|GMAF=0.1001
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 69.8 | 30.2 | 0.0
| HCB | 97.7 | 2.3 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 100.0 | 0.0 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 97.7 | 2.3 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19430482
|Trait=Renal function and chronic kidney disease
|Title=Multiple loci associated with indices of renal function and chronic kidney disease
|RiskAllele=G
|Pval=2E-12
|OR=1.25
|ORtxt=[1.18-1.33]
|OA=1
}}
{{PMID Auto GWAS
|PMID=20383146
|Trait=Chronic kidney disease
|Title=New loci associated with kidney function and chronic kidney disease
|RiskAllele=T
|Pval=1E-20
|OR=None
|ORtxt=None
|OA=1
}}

{{PMID Auto
|PMID=20222955
|Title=A meta-analysis of genome-wide data from five European isolates reveals an association of COL22A1, SYT1, and GABRR2 with serum creatinine level.
|OA=1
}}

{{PMID Auto
|PMID=20686651
|Title=Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs12917707
|overall_frequency_n=13
|overall_frequency_d=128
|overall_frequency=0.101562
|n_genomes=10
|n_genomes_annotated=0
|n_haplomes=10
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{PMID Auto
|PMID=24578125
|Title=Common Variants in UMOD Associate with Urinary Uromodulin Levels: A Meta-Analysis
}}

{{PMID Auto
|PMID=23586973
|Title=Investigation of known estimated glomerular filtration rate loci in patients with Type 2 diabetes.
}}

{{PMID Auto
|PMID=25163389
|Title=UMOD polymorphism rs12917707 is not associated with severe or stable IgA nephropathy in a large Caucasian cohort
}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}